The acute effects of acrylamide on astrocyte functions

Michael Aschner; Cheng Chen Cao; Qi Wu; Marvin A. Friedman

doi:10.1111/j.1749-6632.2003.tb07537.x

The acute effects of acrylamide on astrocyte functions

Michael Aschner, Cheng Chen Cao, Qi Wu, Marvin A. Friedman

Research output: Contribution to journal › Article › peer-review

4 Scopus citations

Abstract

We assessed biochemical endpoints indicative of acute toxicity in neonatal rat primary astrocyte cultures exposed to acrylamide. Metallothionein (MT), glutamine synthetase (GS), glutamate/aspartate transporter (GLAST), and taurine transporter (tau-T) mRNA expression levels as well as cell volume were determined in astrocytes acutely treated with 0.1 and 1.0 mM acrylamide. Statistically significant changes in acrylamide treated astrocytes were noted for GS (0.1 mM) and GLAST (1.0 mM) mRNA expression levels. All other measurements were insignificant in comparison with controls, suggesting that astrocytic function is minimally compromised even at exceedingly high levels of acute acrylamide exposure.

Original language	English (US)
Pages (from-to)	296-304
Number of pages	9
Journal	Annals of the New York Academy of Sciences
Volume	993
DOIs	https://doi.org/10.1111/j.1749-6632.2003.tb07537.x
State	Published - Jan 1 2003
Externally published	Yes

Keywords

Acrylamide
Astrocyte function
Glutamate
Metallothionein

ASJC Scopus subject areas

Neuroscience(all)
Biochemistry, Genetics and Molecular Biology(all)
History and Philosophy of Science

Access to Document

10.1111/j.1749-6632.2003.tb07537.x

Cite this

@article{af2a068033d249c091bb366b23b5571b,

title = "The acute effects of acrylamide on astrocyte functions",

abstract = "We assessed biochemical endpoints indicative of acute toxicity in neonatal rat primary astrocyte cultures exposed to acrylamide. Metallothionein (MT), glutamine synthetase (GS), glutamate/aspartate transporter (GLAST), and taurine transporter (tau-T) mRNA expression levels as well as cell volume were determined in astrocytes acutely treated with 0.1 and 1.0 mM acrylamide. Statistically significant changes in acrylamide treated astrocytes were noted for GS (0.1 mM) and GLAST (1.0 mM) mRNA expression levels. All other measurements were insignificant in comparison with controls, suggesting that astrocytic function is minimally compromised even at exceedingly high levels of acute acrylamide exposure.",

keywords = "Acrylamide, Astrocyte function, Glutamate, Metallothionein",

author = "Michael Aschner and Cao, {Cheng Chen} and Qi Wu and Friedman, {Marvin A.}",

year = "2003",

month = jan,

day = "1",

doi = "10.1111/j.1749-6632.2003.tb07537.x",

language = "English (US)",

volume = "993",

pages = "296--304",

journal = "Annals of the New York Academy of Sciences",

issn = "0077-8923",

publisher = "Wiley-Blackwell",

}

TY - JOUR

T1 - The acute effects of acrylamide on astrocyte functions

AU - Aschner, Michael

AU - Cao, Cheng Chen

AU - Wu, Qi

AU - Friedman, Marvin A.

PY - 2003/1/1

Y1 - 2003/1/1

N2 - We assessed biochemical endpoints indicative of acute toxicity in neonatal rat primary astrocyte cultures exposed to acrylamide. Metallothionein (MT), glutamine synthetase (GS), glutamate/aspartate transporter (GLAST), and taurine transporter (tau-T) mRNA expression levels as well as cell volume were determined in astrocytes acutely treated with 0.1 and 1.0 mM acrylamide. Statistically significant changes in acrylamide treated astrocytes were noted for GS (0.1 mM) and GLAST (1.0 mM) mRNA expression levels. All other measurements were insignificant in comparison with controls, suggesting that astrocytic function is minimally compromised even at exceedingly high levels of acute acrylamide exposure.

AB - We assessed biochemical endpoints indicative of acute toxicity in neonatal rat primary astrocyte cultures exposed to acrylamide. Metallothionein (MT), glutamine synthetase (GS), glutamate/aspartate transporter (GLAST), and taurine transporter (tau-T) mRNA expression levels as well as cell volume were determined in astrocytes acutely treated with 0.1 and 1.0 mM acrylamide. Statistically significant changes in acrylamide treated astrocytes were noted for GS (0.1 mM) and GLAST (1.0 mM) mRNA expression levels. All other measurements were insignificant in comparison with controls, suggesting that astrocytic function is minimally compromised even at exceedingly high levels of acute acrylamide exposure.

KW - Acrylamide

KW - Astrocyte function

KW - Glutamate

KW - Metallothionein

UR - http://www.scopus.com/inward/record.url?scp=0038727653&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0038727653&partnerID=8YFLogxK

U2 - 10.1111/j.1749-6632.2003.tb07537.x

DO - 10.1111/j.1749-6632.2003.tb07537.x

M3 - Article

C2 - 12853321

AN - SCOPUS:0038727653

SN - 0077-8923

VL - 993

SP - 296

EP - 304

JO - Annals of the New York Academy of Sciences

JF - Annals of the New York Academy of Sciences

ER -

The acute effects of acrylamide on astrocyte functions

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this